Latest News
Two recent papers by Dr. Jen Moliterno and her team help physicians better identify patients who may develop seizures alongside meningiomas.
- March 11, 2021
A case study in NPJ Precision Oncology used whole-exome sequencing (WES) to map out the genetic structure of a rare case of gliosarcoma.
- April 19, 2019Source: Women in Tech Spring Event at Case Western Reserve University
Women in Tech Spring Event at Case Western Reserve University
- February 14, 2017
An analysis of a patient’s deadly brain tumor helped doctors at Smilow Cancer Hospital identify new emerging mutations and keep a 55-year old woman alive for more than five years, researchers report in the journal Genome Medicine.
- March 25, 2015
DNA mutations can cause cancer but in some cases, more mutations may mean a better prognosis for patients. A Yale-led comprehensive genomic analysis of more than 700 brain tumors has revealed one such subtype of the most malignant brain tumor, called glioblastoma, or GBM. This subtype possesses thousands of tumor-specific DNA errors or mutations instead of dozens observed in most glioblastoma cases. It is also associated with longer survival.